BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20070483)

  • 21. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
    Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
    Siqueira AS; Carvalho MR; Monteiro AC; Freitas VM; Jaeger RG; Pinheiro JJ
    Histopathology; 2010 Jul; 57(1):128-37. PubMed ID: 20653784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma.
    Ip YC; Cheung ST; Fan ST
    Mol Carcinog; 2007 Mar; 46(3):225-30. PubMed ID: 17219425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity.
    Zhang B; Zhang J; Huang HZ; Chen WL; Tao Q; Zeng DL; Zhang LT; Xu JH
    J Oral Pathol Med; 2009 Oct; 38(9):731-6. PubMed ID: 19473446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression.
    Kim NI; Kim GE; Lee JS; Park MH
    Virchows Arch; 2017 Jan; 470(1):91-98. PubMed ID: 27909812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M; Kanda K; Li NC; Fukumori T; Oka N; Kanayama HO; Kagawa S
    J Urol; 2001 Dec; 166(6):2495-9. PubMed ID: 11696817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer.
    Papathoma AS; Petraki C; Grigorakis A; Papakonstantinou H; Karavana V; Stefanakis S; Sotsiou F; Pintzas A
    Anticancer Res; 2000; 20(3B):2009-13. PubMed ID: 10928143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression.
    Funel N; Costa F; Pettinari L; Taddeo A; Sala A; Chiriva-Internati M; Cobos E; Colombo G; Milzani A; Campani D; Dalle-Donne I; Gagliano N
    Pancreatology; 2010; 10(5):545-52. PubMed ID: 20975318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
    Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
    J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of matrix metalloproteinases in ameloblastomas and pericoronal follicles.
    Dutra KL; Cordeiro MM; Vieira DS; Rivero ER
    J Oral Pathol Med; 2016 Sep; 45(8):586-90. PubMed ID: 26694521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
    Basu A; Rodeck U; Prendergast GC; Howe CC
    Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
    Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.